The recruitment of cells to the site of inflammation is a key step in a wide range of inflammatory diseases (1-4). This event is mediated by the complex interactions of cellular adhesion molecules (2-8). The leukocyte integrins, of which lymphocyte function associated antigen (LFA- 1;CD11a/CD18) is a member, play a critical role in the recruitment of cells to the site of inflammation. (5,9, 10). In order to mediate these cell- cell adhesive interactions, LFA-1 requires activation and this can be achieved through the stimulation of a number of known signal transduction pathways or by antibodies (11-13). Once activated, lFA-1 exhibits enhanced affinity for its ligand (14). Although a significant understanding of the signals that activate LFA-1 has been achieved, little is understood about the exact mechanisms that result in a change in affinity of lFA-1 for its ligands as well as those signals that are triggered by this receptor ligand interaction. We hypothesize that the leukocyte integrin LFA-1 undergoes a conformational change that results in enhanced binding to its ligand subsequent of intracellular signaling pathways. This event requires specific structural features of the LFA-1 molecular and is associated with the initiation of an intracellular signaling cascade. Our specific objectives are to: 1) Determine the structural features of LFA-1 that are required to mediate the change in affinity of lFA-1 for its ligands. Although the role of the beta subunit in avidity regulation has been well defined, that of the alpha subunit has been hampered by the lack of a suitable cell line that does not express LFA-1 but possesses intact signaling machinery(15). We will utilize a cell line that we have isolated that does not express LFA-1 but has preserved intracellular signaling pathways. We will not only define the minimal structural features of the alpha subunit required for activation of lFA-1 but will also define the specificity of the interaction between alpha and beta subunits. 2) Define signal transduction pathways that are modulated upon the interaction of lFA-1 with its ligand, ICAM-1.
This aim will analyze the signals that are generated from the interaction of LFA-1 with its ligand ICAM-1. We will focus our attention to events that are mediated by protein phosphorylation and will utilize an antibody that we have isolated, CBR LFA-1 with ICAM-1 and to define the structural features of lFA-1 that are required for this signaling. Understanding the molecular steps involved with leukocyte integrin activation is critical to a wide array of inflammatory diseases. By defining the molecular details of the recruitment of cells to the site of inflammation we will then be able to, as a long term goal, target steps for therapeutic intervention.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08AI001376-03
Application #
2671403
Study Section
Allergy & Clinical Immunology-1 (AITC)
Project Start
1996-04-01
Project End
2000-03-31
Budget Start
1998-04-01
Budget End
2000-03-31
Support Year
3
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Takami, M; Herrera, R; Petruzzelli, L (2001) Mac-1-dependent tyrosine phosphorylation during neutrophil adhesion. Am J Physiol Cell Physiol 280:C1045-56
Herrera, R; Hubbell, S; Decker, S et al. (1998) A role for the MEK/MAPK pathway in PMA-induced cell cycle arrest: modulation of megakaryocytic differentiation of K562 cells. Exp Cell Res 238:407-14